The FDA has accepted for Priority Review the BLA for sibeprenlimab for the treatment of immunoglobulin A nephropathy in adults.

The global IgA nephropathy market is poised for substantial growth, with sales projected to increase from USD 46,821.7 million in 2025 to a remarkable USD 99,655.4 million by 2035. According to the ...

By Dr. Jonathan Larson and Dr. Hannah Tiffin University of Kentucky Outdoor-loving Kentuckians know that tick bites carry ...

Fantastic Four has been impressing fans since writer Ryan North took over the book, and One World Under Doom has seen the ...

Black holes in a pair of merging galaxies, known as UGC4211, are devouring gas and dust that is "being displaced by the merger," according to ALMA scientists. The Atacama Large ...

Skittles in the US are no longer being made with titanium dioxide, a colour additive that was banned in the European Union in ...